Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.48 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.48 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.48 |
| ▸ | FAAH | O00519 | 2/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.48 |
| ▸ | HTR2C | P28335 | 1/20 | 0.48 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.48 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.48 |
| ▸ | HTR2B | P41595 | 1/20 | 0.48 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL598930 | 0.84 | LMNA (0.57) | GABRA1LMNAGABRG2GABRB3GABRB2 | |
| SCHEMBL28485960 | 0.81 | LMNA (0.55) | GABRA1LMNAGABRG2GABRB3GABRB2 | |
| SCHEMBL199413 | 0.78 | GABRA1 (0.57) | GABRA1LMNAGABRG2GABRB3GABRB2 | |
| SCHEMBL196657 | 0.77 | TSHR (0.50) | GABRA1LMNAGABRG2GABRB3GABRB2 | |
| SCHEMBL23845156 | 0.76 | GABRA1 (0.45) | GABRA1LMNAGABRG2GABRB3GABRB2 | |
| SCHEMBL396706 | 0.76 | GABRA1 (0.52) | GABRA1LMNAGABRG2GABRB3GABRB2 | |
| SCHEMBL22096819 | 0.75 | LMNA (0.48) | GABRA1LMNAGABRG2GABRB3GABRB2 | |
| SCHEMBL2049100 | 0.75 | GABRA1 (0.48) | GABRA1LMNAGABRG2GABRB3GABRB2 | |
| SCHEMBL7087204 | 0.75 | GABRA1 (0.43) | GABRA1LMNAGABRG2GABRB3GABRB2 | |
| SCHEMBL16952315 | 0.73 | LMNA (0.46) | GABRA1LMNAGABRG2GABRB3GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117957265-A | Process for producing dihydroxy compound and process for producing regenerated resin | 三菱瓦斯化学株式会社 | 2024-04-30 | — | — | CN | disclosed |
| WO-2023237755-A1 | COMPOSITION COMPRISING A EUTECTIC MIXTURE COMPRISING AN ALKYLTHIOPHOSPHORIC TRIAMIDE UREASE INHIBITOR | SPECIALTY OPERATIONS FRANCE (FR) | 2023-12-14 | — | — | WO | disclosed |
| EP-3337774-B1 | HIGH TEMPERATURE AMINE-STABILIZED DCD AND/OR ALKYL THIOPHOSPHORIC TRIAMIDE SOLVENT SYSTEMS AND USE IN AGRICULTURAL APPLICATIONS | SPECIALTY OPERATIONS FRANCE (FR) | 2023-12-06 | — | — | EP | disclosed |
| US-11807780-B2 | Aqueous coatings containing biosurfactants as bio-adjuvants and methods for using same | RHODIA OPERATIONS (FR) | 2023-11-07 | — | — | US | disclosed |
| US-20230339994-A1 | CYCLIC PHOSPHAZENE COMPOUND HAVING OXAPHOSPHORIN RING-CONTAINING STRUCTURE | FUSHIMI PHARMACEUTICAL CO., LTD. (JP) | 2023-10-26 | — | — | US | disclosed |
| US-11795119-B2 | Stabilized DCD and/or alkyl thiophosphoric triamide solvent systems and use in agricultural applications | RHODIA OPERATIONS (FR) | 2023-10-24 | — | — | US | disclosed |
| EP-4202013-A1 | CYCLIC PHOSPHAZENE COMPOUND HAVING OXAPHOSPHORIN RING-CONTAINING STRUCTURE | Fushimi Pharmaceutical Co., Ltd. (JP) | 2023-06-28 | — | — | EP | disclosed |
| CN-116194552-A | Cyclic phosphazene compounds having oxaphosphaphenanthrene-containing ring structure | 株式会社伏见制药所 | 2023-05-30 | — | — | CN | disclosed |
| US-11623972-B2 | Substituted catechol monomers, copolymers and methods for use | RHODIA OPERATIONS (FR) | 2023-04-11 | — | — | US | disclosed |
| US-11613508-B2 | Substituted catechol additives in coatings and methods for use | RHODIA OPERATIONS (FR) | 2023-03-28 | — | — | US | disclosed |
| WO-2008157193-A2 | MONO-DI-AND POLYOL PHOSPHATE ESTERS IN PERSONAL CARE FORMULATIONS | RHODIA INC. (US) | 2008-12-24 | — | — | WO | disclosed |
| WO-2008157197-A1 | MONO-, DI- AND POLYOL ALKOXYLATE PHOSPHATE ESTERS IN ORAL CARE FORMULATIONS AND METHODS FOR USING SAME | RHODIA INC. (US) | 2008-12-24 | — | — | WO | disclosed |
| US-20080311055-A1 | MONO-, DI- AND POLYOL ALKOXYLATE PHOSPHATE ESTERS IN ORAL CARE FORMULATIONS AND METHODS FOR USING SAME | RHODIA INC. (US) | 2008-12-18 | — | — | US | disclosed |
| US-20080312120-A1 | Organophosphorus soil release agents; gemini surfactants | RHODIA INC. (US) | 2008-12-18 | — | — | US | disclosed |
| WO-2008154633-A2 | DETERGENT COMPOSITION WITH HYDROPHILIZING SOIL-RELEASE AGENT AND METHODS FOR USING SAME | RHODIA INC. (US) | 2008-12-18 | — | — | WO | disclosed |
| US-20080312341-A1 | MONO-, DI- AND POLYOL PHOSPHATE ESTERS IN PERSONAL CARE FORMULATIONS | RHODIA INC. (US) | 2008-12-18 | — | — | US | disclosed |
| US-20080312118-A1 | HARD SURFACE CLEANING COMPOSITION WITH HYDROPHILIZING AGENT AND METHOD FOR CLEANING HARD SURFACES | RHODIA INC. (US) | 2008-12-18 | — | — | US | disclosed |
| WO-2008154617-A2 | HARD SURFACE CLEANING COMPOSITION WITH HYDROPHILIZING AGENT AND METHOD FOR CLEANING HARD SURFACES | RHODIA INC. (US) | 2008-12-18 | — | — | WO | disclosed |
| US-20080028986-A1 | HYDROPHILIZED SUBSTRATE AND METHOD FOR HYDROPHILIZING A HYDROPHOBIC SURFACE OF A SUBSTRATE | RHODIA, INC. (US) | 2008-02-07 | — | — | US | disclosed |
| WO-2007146956-A2 | HYDROPHILIZED SUBSTRATE AND METHOD FOR HYDROPHILIZING A HYDROPHOBIC SURFACE OF A SUBSTRATE | RHODIA INC. (US) | 2007-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11795119-B2 | Stabilized DCD and/or alkyl thiophosphoric triamide solvent systems and use in agricultural applications | DCTD, DDT, ACMSD | GABRA1 3816/4885LMNA 4700/4885GABRG2 3932/4885 |
| US-20230339994-A1 | CYCLIC PHOSPHAZENE COMPOUND HAVING OXAPHOSPHORIN RING-CONTAINING STRUCTURE | PFAS, PHOSPHO1, PAF1 | GABRA1 2733/4885LMNA 2205/4885GABRG2 2835/4885 |
| US-20080311055-A1 | MONO-, DI- AND POLYOL ALKOXYLATE PHOSPHATE ESTERS IN ORAL CARE FORMULATIONS AND METHODS FOR USING SAME | PHOSPHO1, AGPS, DCPS | GABRA1 2769/4885LMNA 2251/4885GABRG2 2460/4885 |
| US-11613508-B2 | Substituted catechol additives in coatings and methods for use | COMT, DDT, DLAT | GABRA1 2491/4885LMNA 2839/4885GABRG2 2291/4885 |
| US-20080312341-A1 | MONO-, DI- AND POLYOL PHOSPHATE ESTERS IN PERSONAL CARE FORMULATIONS | CUTA, DEK, IPMK | GABRA1 1787/4885LMNA 2353/4885GABRG2 1906/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.